In certain embodiments, any controlled-release otic formulation described herein increases the exposure of an active agent and increases the Area Under the Curve (AUC) in otic fluids (e.g., endolymph and/or perilymph) by about 30%, about 40%, about 50%, about 60%, about 70%, about 80%, about 90%, about 100%, or higher than 100%, compared to an otic formulation that is not a controlled-release otic formulation
In the 12 mg group, every participant lost at least 5 percent, 93 percent lost at least 10 percent, and 83 percent lost at least 15 percent
Embora ele no figure explicitamente na lista de substncias proibidas em 2026, pode ser classificado na categoria dos fatores de crescimento peptdicos (seo S2 da lista de proibies)
DHT blocker, no